A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
NCT07126704
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
FB-101
DRUG:
Placebo for FB-101
Sponsor
1ST Biotherapeutics, Inc.